ArticleMolecular diversity2025

An in silico approach to identify novel and potential Akt1 (protein kinase B-alpha) inhibitors as anticancer drugs.

Umadevi Etikyala et al.PubMed ↗Publisher ↗

No numbers read from the abstract.